Cargando…
1098. Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
BACKGROUND: CAR-T is used to treat certain refractory hematological malignancies. B-cell aplasia and immunosuppression used to treat CAR-T side effects increase infection risk. Little data are available describing Norovirus (NoV) infections in CAR-T recipients. METHODS: We reviewed the medical recor...
Autores principales: | Kondapi, Divya S, Ramani, Sasirekha, Olvera, Adilene, Atmar, Robert L, Estes, Mary K, Okhuysen, Pablo C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777349/ http://dx.doi.org/10.1093/ofid/ofaa439.1284 |
Ejemplares similares
-
700. Risk Factors and Molecular Epidemiology of Acute and Chronic Norovirus Infection at a Large Tertiary Care Cancer Center
por: Kondapi, Divya S, et al.
Publicado: (2021) -
Norovirus in Cancer Patients: A Review
por: Kondapi, Divya Samantha, et al.
Publicado: (2021) -
Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016) -
2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model
por: Cortes-Penfield, Nicolas W, et al.
Publicado: (2019) -
Glycan Recognition in Human Norovirus Infections
por: Tenge, Victoria R., et al.
Publicado: (2021)